Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hematopoietic Stem Cell Therapy for Patients With Inflammatory Multiple Sclerosis Failing Interferon Therapy
NCT00278655Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Jun 2003
- Primary completion
- Dec 2011
- Modality
- Monoclonal Antibodies, Stem Cell Therapies, Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of Hematopoietic Stem Cell Transplantation (Medical College of Wisconsin) in multiple sclerosis (MS), sponsored by Northwestern University. Primary endpoint: Disease Progression at 3 years. Started Jun 2003; status: terminated.
02
Drugs
Hematopoietic Stem Cell Transplantation (Medical College of Wisconsin)
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00278655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00278655.